Related Experiment Video

Updated: Jun 6, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

RNA interference in the clinic: challenges and future directions

Chad V Pecot1, George A Calin, Robert L Coleman

  • 1U.T. M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

Nature Reviews. Cancer
|December 17, 2010
PubMed

Insights

RNA interference (RNAi) offers therapeutic potential, but delivery challenges hinder its use in cancer. This review examines obstacles and new strategies for effective RNAi-based cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Conventional therapeutic approaches face challenges in targeting specific molecules.
  • RNA interference (RNAi) presents a promising alternative for therapeutic intervention.
  • Significant physiological barriers impede the effective delivery of RNAi-based therapeutics.

Purpose of the Study:

  • To review the current challenges in developing synthetic RNAi-based therapies.
  • To explore novel strategies for overcoming biological barriers in RNAi delivery.
  • To discuss methods for achieving controlled and sustained release of RNAi agents.

Main Methods:

  • Literature review of current research on RNAi therapeutics.
  • Analysis of physiological obstacles to RNAi delivery.
  • Exploration of innovative approaches to enhance RNAi efficacy and safety.

Main Results:

  • Identification of key challenges in synthetic RNAi therapy development.
  • Overview of strategies to circumvent biological barriers.
  • Discussion of methods for controlled and sustained release of RNAi agents.

Conclusions:

  • Overcoming delivery challenges is crucial for realizing the therapeutic potential of RNAi.
  • New approaches are needed to improve the safety and efficacy of RNAi-based treatments.
  • Further research into delivery systems and controlled release is essential for clinical translation.

More Related Videos

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Crossing Over01:30

Crossing Over

Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I, duplicated...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...